SCHEMBL6602472

SCHEMBL6602472

CC(C)(N)c1ccc(CN)o1

nearest known ligand 0.39

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 7/20 0.39
CYP2A6 P11509 7/20 0.39
CYP2B6 P20813 7/20 0.39
CYP2C19 P33261 7/20 0.39
CYP2E1 P05181 6/20 0.39
CYP2C9 P11712 5/20 0.39
CYP3A4 P08684 5/20 0.39
CYP1A2 P05177 5/20 0.34
CYP2C8 P10632 4/20 0.34
LOXL2 Q9Y4K0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL5111812 0.89 CYP2E1 (0.37) CYP2D6CYP2A6CYP2B6CYP2C19CYP2E1
SCHEMBL6695496 0.84 CYP2D6 (0.41) CYP2D6CYP2A6CYP2B6CYP2C19CYP2E1
SCHEMBL10983582 0.84 CYP2D6 (0.41) CYP2D6CYP2A6CYP2B6CYP2C19CYP2E1
SCHEMBL7371111 0.81 CYP2E1 (0.38) CYP2D6CYP2A6CYP2B6CYP2C19CYP2E1
SCHEMBL11088334 0.81 ALDH1A1 (0.39) CYP2A6CYP2C19CYP2C9CYP1A2
Hydrochloric Acid SCHEMBL10912134 0.79 ALDH1A1 (0.38) CYP2A6CYP2C19CYP2C9CYP1A2
SCHEMBL19558728 0.79 CYP2E1 (0.37) CYP2D6CYP2A6CYP2B6CYP2C19CYP2E1
SCHEMBL11198860 0.76 ACHE (0.32)
SCHEMBL11172601 0.76 PRMT6 (0.55) CYP2D6CYP2C19CYP2C9CYP3A4CYP1A2
SCHEMBL2478908 0.76 CYP3A4 (0.41) CYP2D6CYP2A6CYP2B6CYP2C19CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436269-A1 OXADIAZOLYL-BIPHENYLCARBOXAMIDES AND THEIR USE AS P38 KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 2004-07-14 EP disclosed
WO-2003033482-A1 OXADIAZOLYL-BIPHENYLCARBOXAMIDES AND THEIR USE AS P38 KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 2003-04-24 WO disclosed